Filana Therapeutics (FLNA) vs Incannex Healthcare (IXHL)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Incannex Healthcare (IXHL) has outperformed Filana Therapeutics (FLNA) over the past year, losing 75.8% versus a loss of 76.1%. Incannex Healthcare is the larger company by market cap ($39.8 million vs $38.4 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | FLNA | IXHL |
|---|---|---|
| Share price | $0.7946 | $3.17 |
| Market cap | $38.39M | $39.79M |
| 1-day change | -2.60% | -0.26% |
| YTD return | -58.80% | -70.39% |
| 1-year return | -76.15% | -75.80% |
| 5-year return | -98.36% | — |
| EPS (TTM) | $-0.87 | $-1.66 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $4.98 | $14.91 |
| 52-week low | $0.67 | $2.49 |
| Distance from 52-week high | -84.04% | -78.73% |
| Average volume | 2.03M | 98.82K |
| Shares outstanding | 48.31M | 12.54M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
FLNA vs IXHL FAQ
Which is bigger, Filana Therapeutics or Incannex Healthcare?
Incannex Healthcare (IXHL) is larger, with a market capitalization of $39.79M compared with $38.39M for Filana Therapeutics (FLNA).
Which stock has performed better over the past year, FLNA or IXHL?
IXHL returned -75.80% over the past 12 months, compared with -76.15% for FLNA (price return, excluding dividends). Past performance does not predict future results.
Are Filana Therapeutics and Incannex Healthcare in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.